Bioray Pharmaceutical Co., Ltd.

This early-stage study tested an experimental drug called BR105 in 31 adults with advanced cancers that no longer responded to standard treatments. The main goals were to check the drug's safety, find the best dose, and see if it could shrink tumors. The study was stopped early, …

This early-stage study tested a new drug called BR108 in 8 adults with advanced blood cancers (lymphoma, leukemia, or myelodysplastic syndrome) that had not responded to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink t…

This early-stage study tested a new drug called BRY805 in 13 people with advanced solid tumors who had no other treatment options. The main goal was to check the drug's safety and find the best dose. The study was terminated early, so results are limited.

This early-stage study aimed to see if a new drug (HS632) works like the approved allergy drug Omalizumab in healthy men. Only one person took part before the study was stopped. The goal was to measure how the drug moves through the body and check for safety.